Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Oncol.

Sec. Cancer Immunity and Immunotherapy

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1641399

This article is part of the Research TopicNew Horizons in Tumor Microenvironment Biology and Therapy: Implications for New Therapies, Volume IIView all 19 articles

Correction: TPL inhibits the invasion and migration of drug-resistant ovarian cancer by targeting the PI3K/AKT/NF-κB-signaling pathway to inhibit the polarization of M2 TAMs

Provisionally accepted
Fuyin LeFuyin Le1Lilan YangLilan Yang2Yiwen HanYiwen Han3Yanying ZhongYanying Zhong1Fuliang ZhanFuliang Zhan1Ying FengYing Feng1Hui HuHui Hu1*Tingtao ChenTingtao Chen3*Buzhen TanBuzhen Tan1*
  • 1Department of Obstetrics & Gynecology, The Second Affiliated Hospital of Nanchang University, Nanchang, China, nanchang, China
  • 2Department of Obstetrics & Gynecology, The First Affiliated Hospital of Nanchang University, Nanchang, China, Nanchang, China
  • 3Institute of Translational Medicine, Nanchang University, Nanchang, China, Nanchang, China

This article is a correction to:

  1. TPL Inhibits the Invasion and Migration of Drug-Resistant Ovarian Cancer by Targeting the PI3K/AKT/NF-κB-Signaling Pathway to Inhibit the Polarization of M2 TAMs

    1. Read original article

The final, formatted version of the article will be published soon.

Select one of your emails

You have multiple emails registered with Frontiers:

Notify me on publication

Please enter your email address:

If you already have an account, please login

You don't have a Frontiers account ? You can register here

Keywords: A2780/DDP cells, Cisplatin (DDP) resistance, Triptolide (TPL), PI3K/AKT/NF-κB- pathway, tumor- associated macrophages (TAMs)

Received: 05 Jun 2025; Accepted: 20 Aug 2025.

Copyright: © 2025 Le, Yang, Han, Zhong, Zhan, Feng, Hu, Chen and Tan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Hui Hu, Department of Obstetrics & Gynecology, The Second Affiliated Hospital of Nanchang University, Nanchang, China, nanchang, China
Tingtao Chen, Institute of Translational Medicine, Nanchang University, Nanchang, China, Nanchang, China
Buzhen Tan, Department of Obstetrics & Gynecology, The Second Affiliated Hospital of Nanchang University, Nanchang, China, nanchang, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Supplementary Material